<?xml version="1.0" encoding="UTF-8"?>
<rss
    xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd"
	xmlns:pa="http://escrs.pictaural-player.com/eyeContact/pa.dtd"
	xmlns:atom="http://www.w3.org/2005/Atom"
    version="2.0">

    <channel>
	<itunes:new-feed-url>http://escrs.pictaural-player.com/eyeContact/eyeContact.xml</itunes:new-feed-url> 
		<atom:link href="http://escrs.pictaural-player.com/eyeContact.xml" rel="self" type="application/rss+xml" />

        <title>Eye Contact</title>
        <description>Eye Contact features interviews with key opinion leaders in the world of ophthalmology.</description>
        <link>http://www.eurotimes.org/</link>

		<docs>http://www.rssboard.org/rss-specification</docs>
        <copyright>(c) ESCRS 2007</copyright>
        <language>en-ie</language>
        <pubDate>Fri, 23 Nov 2007 11:21:54 GMT</pubDate>

        <image>
            <link>http://www.eurotimes.org/</link>
            <title>Eye Contact</title>
            <url>http://escrs.pictaural-player.com/eyeContact/img/EyeContactLogo-small.jpg</url>
            <width>144</width>
            <height>144</height>
        </image>

		<itunes:image href="http://escrs.pictaural-player.com/eyeContact/img/EyeContactLogo-small.jpg" />
        <itunes:explicit>no</itunes:explicit>
		<itunes:category text="Science &amp; Medicine" />
		<itunes:owner>
			<itunes:name>ESCRS</itunes:name>
			<itunes:email>eyeContactEditor@escrs.org (Eye Contact Podcast Editor)</itunes:email>
		</itunes:owner>

		<pa:p_link>escrs.pictaural-player.com/eyeContact/eyeContact.xml</pa:p_link>
	   <item>
             <title>James Mazzo, CEO, AMO</title>
            <description>These are challenging times for the eye care industry in general and for Advanced Medical Optics (AMO) in particular, but AMO chairman and  chief executive officer of James Mazzo is optimistic about the prospects for the future. This interview was conducted shortly before AMO announced it would be acquired by Abbott Laboratories. Mr Mazzo will remain with Abbott as president of AMO after the takeover. </description>
            <link>http://escrs.pictaural-player.com/eyeContact/incl/audio/mazzo2.mp3</link>
            <enclosure url="http://escrs.pictaural-player.com/eyeContact/incl/audio/mazzo2.mp3" length="4896362" type="audio/mpeg"/>
            <guid isPermaLink="false">tag:escrs.org,2009:eyeContact-mazzo</guid>
            <pubDate>Tue, 27 Jan 2009 12:27:25 GMT</pubDate>
            <itunes:subtitle>These are challenging times for the eyecare industry, but Jim Mazzo remains optimistic.</itunes:subtitle>
            <itunes:summary>These are challenging times for the eye care industry in general and for Advanced Medical Optics (AMO) in particular, but AMO chairman and  chief executive officer of James Mazzo is optimistic about the prospects for the future. This interview was conducted shortly before AMO announced it would be acquired by Abbott Laboratories. Mr Mazzo will remain with Abbott as president of AMO after the takeover.</itunes:summary>
            <itunes:duration>11:29</itunes:duration>
            <itunes:author>EuroTimes</itunes:author>
            <itunes:block>no</itunes:block>
			<pa:talk_img>http://escrs.pictaural-player.com/eyeContact/img/JamesMazzo.jpg</pa:talk_img>
       </item>
	   <item>
             <title>Peter Barry FRCS</title>
            <description>US docs question ESCRS study results.
Why are some in the US hesitating to accept the results of the ESCRS Endophthalmitis Study? </description>
            <link>http://podcast-files.pictaural.com.edgesuite-staging.net/barry.mp3</link>
            <enclosure url="http://podcast-files.pictaural.com.edgesuite-staging.net/barry.mp3" length="7023202" type="audio/mpeg"/>
            <guid isPermaLink="false">tag:escrs.org,2008:eyeContact-barry1</guid>
            <pubDate>Thurs, 11 Sep 2008 12:27:25 GMT</pubDate>
            <itunes:subtitle>US docs question ESCRS study results</itunes:subtitle>
            <itunes:summary>Why are some in the US hesitating to accept the results of the ESCRS Endophthalmitis Study?</itunes:summary>
            <itunes:duration>16:43</itunes:duration>
            <itunes:author>EuroTimes</itunes:author>
            <itunes:block>no</itunes:block>
			<pa:talk_img>http://escrs.pictaural-player.com/eyeContact/img/Barry.jpg</pa:talk_img>
       </item>
	   <item>
             <title>Edward J. Holland MD</title>
            <description>Expanding the cornea donor pool
The recently announced results of the Cornea Donor Study suggest a way to significantly expand the supply of corneas available for transplantation. </description>
            <link>http://podcast-files.pictaural.com.edgesuite-staging.net/holland.mp3</link>
            <enclosure url="http://podcast-files.pictaural.com.edgesuite-staging.net/holland.mp3" length="6953612" type="audio/mpeg"/>
            <guid isPermaLink="false">tag:escrs.org,2008:eyeContact-holland1</guid>
            <pubDate>Mon, 23 Jun 2008 12:27:25 GMT</pubDate>
            <itunes:subtitle>Expanding the cornea donor pool</itunes:subtitle>
            <itunes:summary>The recently announced results of the Cornea Donor Study suggest a way to significantly expand the supply of corneas available for transplantation.</itunes:summary>
            <itunes:duration>18:54</itunes:duration>
            <itunes:author>EuroTimes</itunes:author>
            <itunes:block>no</itunes:block>
			<pa:talk_img>http://escrs.pictaural-player.com/eyeContact/img/EdwardJHolland.jpg</pa:talk_img>
       </item>

	   <item>
             <title>Michael Knorz MD</title>
            <description>All-laser LASIK
The innovative practice of using a femtosecond laser to create LASIK flaps has profoundly changed laser refractive surgery. Dr Knorz discussed the advantages of the all-laser approach. </description>
            <link>http://podcast-files.pictaural.com.edgesuite-staging.net/knorz.mp3</link>
            <enclosure url="http://podcast-files.pictaural.com.edgesuite-staging.net/knorz.mp3" length="7994436" type="audio/mpeg"/>
            <guid isPermaLink="false">tag:escrs.org,2008:eyeContact-knorz1</guid>
            <pubDate>Fri, 30 May 2008 12:27:25 GMT</pubDate>
            <itunes:subtitle>All-laser LASIK</itunes:subtitle>
            <itunes:summary>The innovative practice of using a femtosecond laser to create LASIK flaps has profoundly changed laser refractive surgery. Dr Knorz discussed the advantages of the all-laser approach.</itunes:summary>
            <itunes:duration>18:54</itunes:duration>
            <itunes:author>EuroTimes</itunes:author>
            <itunes:block>no</itunes:block>
			<pa:talk_img>http://escrs.pictaural-player.com/eyeContact/img/knorz.jpg</pa:talk_img>
       </item>

	   <item>
             <title>Noel Alpins MD</title>
            <description>Do you perform LASIK based on topographic or wavefront parameters. Noel Alpins describes vector planning, a way to combine the two.</description>
            <link>http://podcast-files.pictaural.com.edgesuite-staging.net/alpins.mp3</link>
            <enclosure url="http://podcast-files.pictaural.com.edgesuite-staging.net/alpins.mp3" length="10370846" type="audio/mpeg"/>
            <enclosure url="http://www.newvisionclinics.com.au/newvision/articles-cat/Vector%20Planning/14%20Vector%20Analysis%20Can%20Improve%20Predictability%20of%20Astigmatism.pdf" length="0" type="text/html"/>
            <guid isPermaLink="false">tag:escrs.org,2007:eyeContact-alpin1</guid>
            <pubDate>Wed, 23 Apr 2008 14:27:25 GMT</pubDate>
            <itunes:subtitle>Vector planning</itunes:subtitle>
            <itunes:summary>Do you perform LASIK based on topographic or wavefront parameters. Noel Alpins describes vector planning, a way to combine the two.</itunes:summary>
            <itunes:duration>10:48</itunes:duration>
            <itunes:author>EuroTimes</itunes:author>
            <itunes:block>no</itunes:block>
			<pa:talk_img>http://escrs.pictaural-player.com/eyeContact/img/AlpinsNoel.jpg</pa:talk_img>
       </item>
	   
        <item>
            <title>Joseph Colin MD</title>
            <description>Chairman, Department of Ophthalmology, University of Bordeaux France. 
What options should surgeons consider in patients who have received potentially risky angle supported phakic IOLs?
Click "url" to view a video illustrating video-Vivarte IOL removal.</description>
            <link>http://podcast-files.pictaural.com.edgesuite-staging.net/colin.mp3</link>
            <enclosure url="http://podcast-files.pictaural.com.edgesuite-staging.net/colin.mp3" length="5653341" type="audio/mpeg"/>
             <enclosure url="http://escrs.pictaural-player.com/eyeContact/incl/ablation_de_GBR.wmv" length="0" type="text/html"/>
			 <guid isPermaLink="false">tag:escrs.org,2007:eyeContact-Colin1</guid>

            <pubDate>Mon, 21 Apr 2008 12:37:25 GMT</pubDate>
            <itunes:subtitle>Angle supported phakic IOLs</itunes:subtitle>
            <itunes:summary>Joseph Colin, Chairman, Department of Ophthalmology, University of Bordeaux France. 
What options should surgeons consider in patients who have received potentially risky angle supported phakic IOLs?
A video illustrating video-Vivarte IOL removal is available from the Eurotimes PodCast Player on the ESCRS website. </itunes:summary>
            <itunes:duration> 05:53</itunes:duration>
            <itunes:author>EuroTimes</itunes:author>
            <itunes:block>no</itunes:block>
			<pa:talk_img>http://escrs.pictaural-player.com/eyeContact/img/ColinJoseph.jpg</pa:talk_img>
       </item>
	   


        <item>
            <title>Dr Emanuel Rosen</title>
            <description>Researchers are now reporting promising results with a solid state laser system known as the Pulzar Z1 from Custom Viz. Dr Emanuel Rosen discusses the latest clinical results and potential advantages of this approach.</description>
            <link>http://podcast-files.pictaural.com.edgesuite-staging.net/rosen.mp3</link>
            <enclosure url="http://podcast-files.pictaural.com.edgesuite-staging.net/rosen.mp3" length="14781709" type="audio/mpeg"/>
             <guid isPermaLink="false">tag:escrs.org,2007:eyeContact-Rosen1</guid>

            <pubDate>Wed, 26 Mar 2008 14:27:25 GMT</pubDate>
            <itunes:subtitle>Pulzar Z1 </itunes:subtitle>
            <itunes:summary>Researchers are now reporting promising results with a solid state laser system known as the Pulzar Z1 from Custom Viz. Dr Emanuel Rosen discusses the latest clinical results and potential advantages of this approach.</itunes:summary>
            <itunes:duration> 08:14</itunes:duration>
            <itunes:author>EuroTimes</itunes:author>
            <itunes:block>no</itunes:block>
			<pa:sponsor>
				<pa:sp_img>http://neoireland.pictaural-player.com/eventsDay07/sponsor1.jpg</pa:sp_img>
				<pa:sp_url>http://www.pictaural-player.com</pa:sp_url>
			</pa:sponsor>
			<pa:talk_img>http://escrs.pictaural-player.com/eyeContact/img/Rosen-Emanuel.jpg</pa:talk_img>
       </item>

        <item>
            <title>Dr. Thomas Kohnen</title>
            <description>Phakic IOLs occupy a small but growing niche in the refractive vision correction world. These lenses would seem to offer a good option to younger patients, a reversible procedure offering excellent refractive correction especially in high myopia, without compromising accommodative vision. While many clinical trials confirm their benefits, recent moves by French regulatory agencies to ban certain anterior chamber phakic IOLs highlight lingering concerns about potential problems.</description>
            <link>http://podcast-files.pictaural.com.edgesuite-staging.net/kohnen.mp3</link>
            <enclosure url="http://podcast-files.pictaural.com.edgesuite-staging.net/kohnen.mp3" length="14781709" type="audio/mpeg"/>
            <enclosure url="http://www.escrs.org/Publications/Eurotimes/default.asp?category=Special%20Focus%20-%20Phakic%20IOLs&amp;year=2007&amp;month=11" length="0" type="text/html"/>
            <guid isPermaLink="false">tag:escrs.org,2007:eyeContact-Kohnen1</guid>

            <pubDate>Wed, 21 Nov 2007 14:27:25 GMT</pubDate>
            <itunes:subtitle>Phakic IOLs </itunes:subtitle>
            <itunes:summary>Phakic IOLs occupy a small but growing niche in the refractive vision correction world.These lenses would seem to offer a good option to younger patients, a reversible procedure offering excellent refractive correction especially in high myopia, without compromising accommodative vision.While many clinical trials confirm their benefits, recent moves by French regulatory agencies to ban certain anterior chamber phakic IOLs highlight lingering concerns about potential problems.</itunes:summary>
            <itunes:duration>15:24</itunes:duration>
            <itunes:author>EuroTimes</itunes:author>
            <itunes:block>no</itunes:block>
			<pa:sponsor>
				<pa:sp_img>http://neoireland.pictaural-player.com/eventsDay07/sponsor1.jpg</pa:sp_img>
				<pa:sp_url>http://www.pictaural-player.com</pa:sp_url>
			</pa:sponsor>
			<pa:talk_img>http://escrs.pictaural-player.com/eyeContact/img/kohnen.jpg</pa:talk_img>
       </item>


    </channel>
</rss>
